Because of copyright laws, samples in their entirety cannot be provided here. Please contact us if you would like us to send samples to you.
Online CME Articles and Webinars:
Assessing the Current State of Multiple Sclerosis Management
Predicting the Course of Multiple Sclerosis: Implications for Treatment (webinar)
Scientific Articles and Posters:
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomized, double-blind, placebo-controlled trial. The Lancet Oncology. Published online December, 2008.
Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy. J Clin Oncol. 2009; 27:5363-5369.
The book chapter, "Targeted Therapies for Hepatocellular Carcinoma" in Hepatocellular Carcinoma: Diagnosis and Treatment (published in September 22, 2009).
Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine. Neuropsychiatr Dis Treat. 2010; 6: 317–327.
Oncology Medical Writing Services, Inc.
New York, NY
Phone: 646-389-9391
email: kralian@oncomedwriter.com